This announcement is a separate document:
恩华药业:关于注射用甲磺酸齐拉西酮通过仿制药一致性评价的公告
Enhua Pharmaceutical: Announcement on whether injectable ziprasidone mesylate passed the generic drug consistency evaluation
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.